Fate Therapeutics Reports Second Quarter 2020 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Second Quarter 2020 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 1.87 -0.19 (9.22%)
Previous Close $2.06    52 Week High $4.76 
Open $2.09    52 Week Low $1.46 
Day High $2.15    P/E N/A 
Day Low $1.81    EPS $-1.91 
Volume 6,687,089